Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models
2021
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Inference and analysis of cell-cell communication using CellChat
2021 Standout
Combination versus mono-therapy as salvage treatment for advanced biliary tract cancer: A comprehensive meta-analysis of published data
2019
A Randomised Open-Label Trial Comparing Long-term Sub-Cutaneous Low-Molecular-weight Heparin Compared with Oral-Anticoagulant Therapy in the Treatment of Deep Venous Thrombosis
2009
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Multiple roles of CD90 in cancer
2016
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
2010
The biology and management of non-small cell lung cancer
2018 StandoutNature
Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trials
2013
Prevention of Venous Thromboembolism in Neurosurgery
2008
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism
2012
Antithrombotic Therapy for VTE Disease
2016 Standout
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Lung Cancer in Never Smokers
2011
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
An ionizable lipid toolbox for RNA delivery
2021 StandoutNobel
Lung cancer: current therapies and new targeted treatments
2016 Standout
Cancer-associated cachexia
2018 Standout
Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis
2006
Antithrombotic Therapy for VTE Disease
2012 Standout
Not all immune-checkpoint inhibitors are created equal: Meta-analysis and systematic review of immune-related adverse events in cancer trials
2017
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
2011 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
The treatment of venous thromboembolism with low-molecular-weight heparins
2012
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Role of PD-1 in Immunity and Diseases
2017 StandoutNobel
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Long-Term Use of Different Doses of Low-Molecular-Weight Heparin Versus Vitamin K Antagonists in the Treatment of Venous Thromboembolism
2009
Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis
2016
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
2020 Standout
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy
2014
MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular Carcinoma
2020
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
2011
Immune Modulation in Cancer with Antibodies
2013 StandoutNobel
Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse Events
2016
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
The emerging role of immune checkpoint based approaches in AML and MDS
2017 StandoutNobel
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring BRAF Mutations
2011
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
2014 Standout
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Ipilimumab for Patients With Advanced Mucosal Melanoma
2013
Immune Checkpoint Inhibitors in Melanoma
2015
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of Carmen Nuzzo being referenced
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials
2006
Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: Pooled-analysis of 8794 patients
2006
Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme
2014
Is Recurrent Venous Thromboembolism After Therapy Reduced by Low-Molecular-Weight Heparin Compared With Oral Anticoagulants?
2006
PTEN: Multiple Functions in Human Malignant Tumors
2015
Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma
2013
Clinical Implications of KRAS Mutations in Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors: An Important Role for Mutations in Minor Clones
2009
Oral ondansetron is highly active as rescue antiemetic treatment for moderately emetogenic chemotherapy: results of a randomized phase II study
2008
Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers
2009
Efficacy and Safety of Ipilimumab in Patients with Pretreated, Mucosal Melanoma: Experience from Italian Clinics Participating in the European Expanded Access Programme (EAP)
2012
Bone and lung metastases from intracranial meningioma.
2006
Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: Pooled-analysis of 8,794 patients
2006